Enhanced glucose-stimulated insulin secretion is a common compensatory mechanism in β cells under an increased workload (e.g. insulin resistance), but compensation often turns into decompensation, resulting in the development of type 2 diabetes (58). This evidence concerns the gene INS and type 2 diabetes mellitus.